ArticleJournal of nanobiotechnology2026
Carbon-based quantum dots enhance platelets aggregation through migrasomes biogenesis.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
While previous research has primarily focused on nanoparticles larger than 20 nm for promoting migrasome formation, this study shifts the emphasis to nanoparticles smaller than 10 nm. Our findings reveal the significant impact of these sub-10 nm carbon-based quantum dots, specifically carbon quantum dots (CQD), graphene quantum dots (GQD), and graphitic oxide quantum dots (GOQDs), on migrasome formation, mitochondrial integrity, and platelet function. We establish a clear correlation between the application of these nanoparticles and the induction of migrasomes. Furthermore, our results indicate that CQD, GQD, and GOQDs enhance migrasome formation by upregulating phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), cholesterol, and GTP-RhoA. Additionally, these nanoparticles provide mitochondrial protection through a process called mitocytosis and promote increased platelet aggregation. This study represents a pioneering effort to connect various types of nanoscale graphene materials with the dynamic behavior of migrasomes, thereby advancing our understanding of nanoscale materials and their biological implications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.